BTV examines the growing psychedelic market


Receive instant alerts for news on your actions. Claim your 1-week free trial for StreetInsider Premium here.

Vancouver, British Columbia – (Newsfile Corp. – Aug. 17, 2021) – Sun Aug. 22sd at 5 p.m. EST broadcast on FOX Business News BTV-Business Television explores the booming industry that has caught the attention of investors – psychedelics.

Can’t see this video? Visit:

Find out which companies to invest in – Click on the name of the company to watch its TV function:

Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF)

Research and development of DMT, one of the most potent psychedelics available, to treat substance use disorders related to nicotine, alcohol and opioids. Elemer Piros, analyst at Roth Capital Partners, weighs.

Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF)

BTV reports on their ongoing preclinical studies with a proprietary extract of the poisonous fungus Amanita Muscaria.

Petite Pharma inc. (TSXV: DMT)

BTV discovers DMT, a psychedelic that is the subject of a Small Pharma clinical trial for depression, the first in the world.

Numinus Well-being Inc. (TSXV: NUMI)

BTV talks to a company at the forefront of a new and innovative mental health treatment focused on assisted psychedelic psychotherapy.

Mydecine Innovations Group (NEO: MYCO) (Rose OTC: MYCOF)

BTV discovers how this company is developing psilocybin-based psychedelic treatments to better treat the effects of addiction and post-traumatic stress disorder.

On the air for over 20 years, BTV – Business Television, a half-hour TV show on investing, features analysts and emerging listed companies at their location. With hosts, Taylor thoen and Jessica katrichak, BTV offers viewers investment opportunities.

Suggest a company to present!
Contact: (604) 664-7401 x3 [email protected]

To view the source version of this press release, please visit


Leave A Reply